EXEL - Exelixis, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue191,45437,17225,111
Cost of Revenue6,5523,8952,043
Gross Profit184,90233,27723,068
Operating Expenses
Research Development95,96796,351189,101
Selling General and Administrative116,14557,30550,829
Non Recurring9141,0427,596
Total Operating Expenses---
Operating Income or Loss-28,124-121,421-224,458
Income from Continuing Operations
Total Other Income/Expenses Net-9,0384124,341
Earnings Before Interest and Taxes-37,162-121,009-220,117
Interest Expense33,06040,68041,362
Income Before Tax-70,222-161,689-261,479
Income Tax Expense-55-182
Minority Interest---
Net Income From Continuing Ops-70,222-161,744-261,297
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-70,222-161,744-261,297
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-70,222-161,744-261,297